Decoy Therapeutics is trading 10.04% up at $2.96, with no confirmed announcement directly explaining the pre-market gain.
- It closed at $2.67 on September 11, 2026.
- A September 14, 2026 special shareholder meeting will cover Series A, B, and C warrant exercises and an authorized-share amendment.
- Broader markets are weaker, so the move does not appear tied to overall market direction.